Photo by myriamzilles from unsplash
We evaluate whether the Pro12Ala polymorphism of peroxisome proliferator‐activated receptor γ2 (PPARγ2) has a role in the progression of diabetes by modulating the occurrence of treatment failure to glucose‐lowering drugs. Click to show full abstract
We evaluate whether the Pro12Ala polymorphism of peroxisome proliferator‐activated receptor γ2 (PPARγ2) has a role in the progression of diabetes by modulating the occurrence of treatment failure to glucose‐lowering drugs.
Keywords:
ppar;
failure;
lowering drugs;
pro12ala polymorphism;
glucose lowering
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!